129 related articles for article (PubMed ID: 10604273)
1. Differential effects of talipexole and bromocriptine on serotonin release from rat intestinal tissues--an in vitro study of the emetic response of antiparkinsonian dopamine agonists.
Minami M; Kohno Y; Endo T; Nemoto M; Ogawa T; Ihira E; Hamaue N; Hirafuji M
Res Commun Mol Pathol Pharmacol; 1999; 104(1):3-12. PubMed ID: 10604273
[TBL] [Abstract][Full Text] [Related]
2. Effects of talipexole on emesis-related changes in abdominal afferent vagal activity and ileal serotonin metabolism in rats.
Minami M; Nemoto M; Endo T; Hamaue N; Kohno Y
Res Commun Mol Pathol Pharmacol; 1997 Jan; 95(1):67-82. PubMed ID: 9055350
[TBL] [Abstract][Full Text] [Related]
3. Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine.
Minami M; Tamakai H; Ogawa T; Endo T; Hamaue N; Hirafuji M; Yoshioka M; Blower PR
Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):131-42. PubMed ID: 8556268
[TBL] [Abstract][Full Text] [Related]
4. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
[TBL] [Abstract][Full Text] [Related]
5. Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model.
Endo T; Hamaue N; Ihira E; Teramoto Y; Liu Y; Hirafuji M; Minami M
Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):55-68. PubMed ID: 14632314
[TBL] [Abstract][Full Text] [Related]
6. Granisetron, a 5-HT3 receptor antagonist, inhibited cisplatin-induced 5-hydroxytryptamine release in the isolated ileum of ferrets.
Endo T; Ogawa T; Hamaue N; Akita K; Hirafuji M; Minami M; Blower PR
Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):243-53. PubMed ID: 9730004
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide increases 5-hydroxytryptamine release from the isolated ileum of the rat.
Minami M; Ogawa T; Endo T; Hamaue N; Hirafuji M; Yoshioka M; Blower PR; Andrews PL
Res Commun Mol Pathol Pharmacol; 1997 Jul; 97(1):13-24. PubMed ID: 9507564
[TBL] [Abstract][Full Text] [Related]
8. Effects of granisetron, a selective 5-HT3 receptor antagonist, on ouabain-induced emesis in ferrets.
Endo T; Sugawara J; Nemoto M; Minami M; Blower PR
Res Commun Mol Pathol Pharmacol; 1998 Dec; 102(3):227-39. PubMed ID: 10342910
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
Oda T; Kume T; Izumi Y; Takada-Takatori Y; Niidome T; Akaike A
Eur J Pharmacol; 2008 Nov; 598(1-3):27-31. PubMed ID: 18835264
[TBL] [Abstract][Full Text] [Related]
10. Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
Kohno Y; Fukuzaki K; Kitahara K; Koja T
Eur J Pharmacol; 1997 Jan; 319(2-3):197-205. PubMed ID: 9042591
[TBL] [Abstract][Full Text] [Related]
11. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
Sprah L; Zivin M; Sket D
J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
[TBL] [Abstract][Full Text] [Related]
12. [Comparative studies on antiparkinsonian agents, talipexole and bromocriptine, evaluated by contralateral rotational behavior in unilaterally nigral-lesioned rats].
Hironaka N; Kohno Y; Yanagita T
Nihon Yakurigaku Zasshi; 1998 Oct; 112(4):257-66. PubMed ID: 9866843
[TBL] [Abstract][Full Text] [Related]
13. 5-HT3 receptor blocking properties of the antiparkinsonian agent, talipexole.
Nishio H; Kohno Y; Fujii A; Negishi Y; Inoue A; Nakata Y
Gen Pharmacol; 1996 Jul; 27(5):779-85. PubMed ID: 8842679
[TBL] [Abstract][Full Text] [Related]
14. Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons.
Matsubayashi H; Amano T; Hongjing Y; Kohno Y; Sasa M
Psychopharmacology (Berl); 1995 Aug; 120(4):369-75. PubMed ID: 8539316
[TBL] [Abstract][Full Text] [Related]
15. Effects of mu-CPP and mesulergine on dietary choices in deprived rats: possible mechanisms of their action.
Antonatos S; Galanopoulou P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):112-9. PubMed ID: 16242827
[TBL] [Abstract][Full Text] [Related]
16. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Dhir A; Kulkarni SK
Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
[TBL] [Abstract][Full Text] [Related]
17. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats.
Lahlou S
Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583
[TBL] [Abstract][Full Text] [Related]
18. [Do renal vascular D2 receptors exist?].
Barthelmebs M; Krieger JP; Grima M; Imbs JL
Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1211-3. PubMed ID: 1953269
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
20. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
